Cargando…

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma

PURPOSE: It has previously been shown that increased wait times for prostatectomy are associated with poorer outcomes in intermediate-risk prostatic carcinoma (PCa). However, the impact of wait times on PCa outcomes following low-dose-rate brachytherapy (LDR-BT) are unknown. METHODS AND MATERIALS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanolkar, Rutvij A., Quon, Harvey, Thind, Kundan, Sia, Michael, Roumeliotis, Michael, Husain, Siraj, McGeachy, Philip, Meyer, Tyler, Martell, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283023/ https://www.ncbi.nlm.nih.gov/pubmed/34307912 http://dx.doi.org/10.1016/j.ctro.2021.06.008

Ejemplares similares

Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
por: Martell, Kevin, et al.
Publicado: (2020)

Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer
por: Samson, Nina, et al.
Publicado: (2021)

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

Analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy()
por: Martell, Kevin, et al.
Publicado: (2020)

Indications for additional volume studies for gland volume estimation in prostate cancer brachytherapy
por: Khanolkar, Rutvij A, et al.
Publicado: (2022)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017)

Development of a Machine Learning Model for Optimal Applicator Selection in High-Dose-Rate Cervical Brachytherapy
por: Stenhouse, Kailyn, et al.
Publicado: (2021)

Corrigendum: Development of a Machine Learning Model for Optimal Applicator Selection in High-Dose-Rate Cervical Brachytherapy
por: Stenhouse, Kailyn, et al.
Publicado: (2021)

The impact of inter-fraction changes for perineal template-based interstitial gynecologic brachytherapy implants
por: Belliveau, Jean-Guy, et al.
Publicado: (2019)

Assessment of dose to vaginal mucosa for gynecologic template interstitial high-dose-rate brachytherapy using Monte Carlo simulation
por: Elburg, Devin Van, et al.
Publicado: (2023)

Matrix reboot: IL-17 signals CAFs to create a second tumor T cell checkpoint
por: McGeachy, Mandy J.
Publicado: (2022)

Post-implant analysis in permanent breast seed implant: automated plan reconstruction using simulated annealing
por: Watt, Elizabeth, et al.
Publicado: (2019)

CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis
por: Hernandez-Mir, Gerard, et al.
Publicado: (2017)

Women on the liver transplantation waitlist are at increased risk of hospitalization compared to men
por: Rubin, Jessica B, et al.
Publicado: (2019)

The metabolism-modulating activity of IL-17 signaling in health and disease
por: Bechara, Rami, et al.
Publicado: (2021)

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
por: Merrick, Gregory S., et al.
Publicado: (2015)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2018)

Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma
por: Sunil, R.A., et al.
Publicado: (2018)

The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly
por: Sidrauski, Carmela, et al.
Publicado: (2015)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020)

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021)

Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era
por: Clarke, Candice, et al.
Publicado: (2020)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses
por: Khanolkar, Rutvij A., et al.
Publicado: (2022)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
por: Abakay, Candan Demiroz, et al.
Publicado: (2022)

Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients
por: Arisar, Fakhar Ali Qazi, et al.
Publicado: (2023)

Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy
por: Dattoli, Michael, et al.
Publicado: (2010)

Access to the Kidney Transplant Waitlist for People With HIV
por: Shelton, Brittany A., et al.
Publicado: (2023)

Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
por: Yu, Hao, et al.
Publicado: (2016)

Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution
por: Anderson, Elliot, et al.
Publicado: (2021)

Definitions of “Cure” After Low-Dose-Rate Brachytherapy in Low- and Intermediate-Risk Prostate Cancer: Phoenix or Surgical?
por: Boehle, Andreas, et al.
Publicado: (2022)

Verification of Acuros XB dose algorithm using 3D printed low‐density phantoms for clinical photon beams
por: Zavan, Rodolfo, et al.
Publicado: (2018)

Surveying the global landscape of post-transcriptional regulators
por: Reynaud, Kendra, et al.
Publicado: (2023)

Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma
por: Weinfurtner, Kelley, et al.
Publicado: (2020)

Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points
por: Goyes, Daniela, et al.
Publicado: (2021)

Efficacy of a transdiagnostic, prevention-focused program for at-risk young adults: a waitlist-controlled trial
por: DeTore, Nicole R., et al.
Publicado: (2023)

Temporary consumption of western diet trains the immune system to reduce future gut inflammation
por: Wu, Dongwen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e64j3ab6aidg3fj21c9u1t9476